Childhood, adolescent and young adult cancer survivors may develop treatment-induced hypothalamic-pituitary dysfunction. Because of this risk, at-risk survivors may benefit from surveillance of hypothalamic-pituitary dysfunction surveillance. This guideline describes the groups at risk and the surveillance recommended for this group
Quality of LifeAllGuidelines
IGHG Guideline on Hypothalamic-Pituitary Dysfunction
Recommendations for surveillance for hypothalamic-pituitary dysfunction in survivors
Year:2021
Discussion & Questions
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Leave a Comment
No comments yet
Be the first to share your thoughts!
Related Resources
Beat Cancer: Building a Transformative European Network of Youth Cancer Survivors - Enhancing Quality of Life, Adolescent Care, Diversity and Inclusion
Explore the EU-CAYAS-NET project, a pioneering EU-funded initiative advancing the quality of life for youth cancer survi...
UpdatedSurvivorshipAll
Read
YCE Addresses the "Cross Border Health Directive" at the European Parliament
In 2019 Youth Cancer Europe addressed the subject of Cross Border Health at the European Parliament; the second of five...
UpdatedCross-border HealthcareAll
Read
#removelabels Social Awareness Campaign
Youth Cancer Europe's social awareness campaign aims at removing stigmas associated with cancer diagnosis amongst young...
UpdatedMental HealthAll
Read